CHIT1 and COVID-19: Studies are currently underway to determine whether patients who have died from COVID-19 have increased CHIT1 expression in their lung tissues, which may lead to a positive effect of OATD-01 on the pulmonary fibrotic development of the disease (Dymek et al., 2018).